Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)

Br J Haematol. 2019 Sep;186(5):e123-e126. doi: 10.1111/bjh.15964. Epub 2019 May 20.
No abstract available

Keywords: deferasirox; iron chelation therapy; myelofibrosis.

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Deferasirox / pharmacology
  • Deferasirox / therapeutic use*
  • Female
  • Humans
  • Iron Chelating Agents / pharmacology
  • Iron Chelating Agents / therapeutic use*
  • Iron Overload / drug therapy*
  • Male
  • Primary Myelofibrosis / complications
  • Primary Myelofibrosis / drug therapy*
  • Retrospective Studies

Substances

  • Iron Chelating Agents
  • Deferasirox